Home ***** welcome to Free Medical video!
Members
Username:

Password:

 Remember me
You have 49 more plays before you must register
Register
Most Popular
Statistics
Total Files: 520
views Today: 446
Overall views: 1,363,790
Total Members: 4,924
Users online: 8 (0 members, 8 guests)
Top Players
Dr.Hady (1,491 plays)
kareem (1,137 plays)
hashimato (1,056 plays)
3328367 (795 plays)
hodifa (433 plays)
Search

Free Medical video > Clinical examination > New Warnings for MRI Contrast Agents Containing Gadolinium
To download normal birth video click here
File Info
Title: New Warnings for MRI Contrast Agents Containing Gadolinium
Description: The labeling for imaging contrast agents that contain gadolinium will soon have strong new warnings. These contrast agents are often used to improve the visibility of internal structures when patients undergo MRI procedures. Five of them have been approved in the US: Magnevist, MultiHance, Omniscan, OptiMARK, and ProHance. The new boxed warning describes risk factors and screening procedures for a serious condition related to gadolinium exposure called nephrogenic systemic fibrosis (NSF). NSF is characterized by fibrosis of the skin, muscle and internal organs. It is debilitating and potentially fatal. The warning will state that certain patients have a higher risk of developing NSF if they are given a gadolinium-based agent. They include those with severe renal failure, whether acute or chronic, and those with acute renal failure of any severity who have hepato-renal syndrome or are in the perioperative period around liver transplantation. Clinicians should avoid using gadolinium based contrast agents with high-risk patients unless the diagnostic information is essential and cannot be obtained any other way. The new labeling will contain several other recommendations, including: • Before using these agents, all patients should be evaluated for renal failure either by obtaining a medical history or conducting laboratory tests. • When administering these products, do not exceed the dose recommended in the product labeling. And do not re-administer these agents until enough time has elapsed to ensure that the prior dose has been eliminated from the body. • After administering a gadolinium-based contrast agent, consider prompt dialysis for patients already receiving hemodialysis. It is unknown whether dialysis prevents NSF, but data indicate that it does speed up the elimination of the agent from the body
views: 449 times
Rating: 3
Rate
Tell a Friend
Comments:
Please login or register to leave a comment.
Add this file to your website:
Related Files:
OSTEOPATHIC TREATMENT OF BIRD FLU PANDEMIC OSTEOPATHIC TREATMENT OF BIRD FLU PANDEMIC
OSTEOPATHIC TREATMENT OF BIRD FLU PANDEMIC
(Played: 346 times)
The physiological effect of asthma The physiological effect of asthma
The physiological effect of asthma
(Played: 298 times)
Respiratory Examination Respiratory Examination
Respiratory Examination
(Played: 1,574 times)
 Acne Acne
Acne,are the people that deal with acne on a regular basis. Watch to learn th...
(Played: 1,100 times)
Schizophrenia genetics Schizophrenia genetics
Dr. David Braff, Professor of Psychiatry at UCSD, discusses schizophrenia wit...
(Played: 485 times)
Top search queries: childbirth video - free medical video - Medical videos - breast cancer awareness - video of Autopsy - Catheter insertion - surgery Video -  methothelioma  - gynecology video -Autopsy videos- Medical videos -Weight loss - Medical video - normal birth - Mesothelioma new - Autopsy video - catheter insertion - clinical examination - pediatric exam video - laparoscopic hysterectomy video - Real autopsy

All videos copyright © to their respective owner s. All rights reserved. developed by 3rbdr Medicalive.Net